These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17620449)

  • 1. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
    Tso AW; Xu A; Sham PC; Wat NM; Wang Y; Fong CH; Cheung BM; Janus ED; Lam KS
    Diabetes Care; 2007 Oct; 30(10):2667-72. PubMed ID: 17620449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.
    Yeung DC; Xu A; Cheung CW; Wat NM; Yau MH; Fong CH; Chau MT; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1796-802. PubMed ID: 17510463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating adipocyte fatty acid binding protein levels in healthy preterm infants: Positive correlation with weight gain and total-cholesterol levels.
    Siahanidou T; Margeli A; Davradou M; Apostolakou F; Papassotiriou I; Roma E; Mandyla H; Chrousos G
    Early Hum Dev; 2010 Apr; 86(4):197-201. PubMed ID: 20231079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.
    Yun KE; Kim SM; Choi KM; Park HS
    Metabolism; 2009 Jun; 58(6):798-802. PubMed ID: 19368945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.
    Tam WH; Ma RC; Yang X; Ko GT; Tong PC; Cockram CS; Sahota DS; Rogers MS; Chan JC
    Pediatrics; 2008 Dec; 122(6):1229-34. PubMed ID: 19047239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
    Guerrero-Romero F; Rascón-Pacheco RA; Rodríguez-Morán M; de la Peña JE; Wacher N
    Eur J Clin Invest; 2008 Jun; 38(6):389-96. PubMed ID: 18489400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population].
    YE WH; PENG XH; AI YQ; CHEN H; ZHANG H; CAI DH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):508-11. PubMed ID: 21421494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change?
    Engl J; Ciardi C; Tatarczyk T; Kaser S; Laimer M; Laimer E; Weiss H; Aigner F; Molnar C; Tilg H; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2008 Aug; 16(8):1838-42. PubMed ID: 18535557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.
    Yeung DC; Wang Y; Xu A; Cheung SC; Wat NM; Fong DY; Fong CH; Chau MT; Sham PC; Lam KS
    Eur Heart J; 2008 Sep; 29(17):2156-63. PubMed ID: 18603624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up.
    Cicero AF; Dormi A; Nascetti S; Panourgia MP; Grandi E; D'Addato S; Gaddi A
    Diabet Med; 2005 Sep; 22(9):1263-6. PubMed ID: 16108859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia.
    Karpisek M; Stejskal D; Kotolova H; Kollar P; Janoutova G; Ochmanova R; Cizek L; Horakova D; Yahia RB; Lichnovska R; Janout V
    Eur J Clin Invest; 2007 Aug; 37(8):637-42. PubMed ID: 17635574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
    Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ
    Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
    J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of adipocyte fatty acid-binding protein to adiponectin ratio with femoral intima-media thickness and endothelium-dependent vasodilation in patients with newly-diagnosed type 2 diabetes mellitus].
    Xiao Y; Yao L; Li X; Zhong H; Chen XY; Tang WL; Liu SP; Xu AM; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):231-5. PubMed ID: 20356535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.